Bressler, N. M., Odia, I., Maguire, M., Glassman, A. R., Jampol, L. M., MacCumber, M. W., . . . Sun, J. K. (2019). Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial. JAMA Ophthalmol.
Citação norma ChicagoBressler, Neil M., Isoken Odia, Maureen Maguire, Adam R. Glassman, Lee M. Jampol, Mathew W. MacCumber, Chirag Shah, Daniel Rosberger, and Jennifer K. Sun. "Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial." JAMA Ophthalmol 2019.
Citação norma MLABressler, Neil M., et al. "Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial." JAMA Ophthalmol 2019.